WebApr 22, 2024 · Hikma Pharmaceuticals has acquired US-based generic sterile injectables company Custopharm from Water Street Healthcare Partners in a deal valued at $425m. … WebThe up-front consideration of $375 million is on a cash-free, debt-free basis and is being funded from Hikma’s existing cash resources. The acquisition constitutes a Class 2 transaction pursuant to the UK Listing Rules. The gross assets of Custopharm at 31 December 2024 were $43 million. Losses before tax in the year to 31 December 2024 …
Hikma strengthens US Injectables business through acquisition of …
WebSep 27, 2024 · Custopharm, a US-based generic sterile injectables company, is a growing business and Hikma expects it to generate full year 2024 revenue in excess of $80 million … WebApr 12, 2024 · Hikma, which means “wisdom” in Arabic, was founded in Jordan in 1978 and supplies various generic drugs including anaesthetics, pain medications, sedatives, neuromuscular blocking agents and anti-infectives. ... In April 2024, the company completed the acquisition of California-based Custopharm in a deal valued at $425 million, as part of ... how to run a mounted iso
Hikma Pharmaceutical agrees to buy Custopharm for $375 million
WebApr 12, 2024 · Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been appointed Chi. Skip to content. 12 April، 2024 . DGN Gate. News from Dubai. Mobiles. OPPO Set To Introduce The Reno8 T Series With 108MP Portrait Camera In The GCC Market. WebSep 27, 2024 · Hikma Pharmaceuticals said on Monday it would buy U.S.-based sterile injectables firm Custopharm in a deal worth up to $425 million, as the generic medicines … WebSep 27, 2024 · 27 Sep, 2024 07:26 29 Jun, 2024 02:36 Hikma buys Custopharm for $375m Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt... how to run an 800m race